132 related articles for article (PubMed ID: 6170200)
1. Prognostic value of thyrotrophin binding inhibiting immunoglobulins (TBII) in longterm antithyroid treatment, 131I therapy given in combination with carbimazole and in euthyroid ophthalmopathy.
Bliddal H; Kirkegaard C; Siersbaek-Nielsen K; Friis T
Acta Endocrinol (Copenh); 1981 Nov; 98(3):364-9. PubMed ID: 6170200
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.
Maugendre D; Massart C
Clin Endocrinol (Oxf); 2001 Jan; 54(1):89-96. PubMed ID: 11167931
[TBL] [Abstract][Full Text] [Related]
3. Thyrotrophin binding inhibiting immunoglobulins in Graves' disease before, during and after antithyroid therapy, and its relation to long-acting thyroid stimulator.
Docter R; Bos G; Visser TJ; Hennemann G
Clin Endocrinol (Oxf); 1980 Feb; 12(2):143-53. PubMed ID: 6105023
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of serum basal thyrotrophin levels and thyrotrophin receptor antibody activities as prognostic markers for discontinuation of antithyroid drug treatment in patients with Graves' disease.
Cho BY; Shong MH; Yi KH; Lee HK; Koh CS; Min HK
Clin Endocrinol (Oxf); 1992 Jun; 36(6):585-90. PubMed ID: 1358483
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment.
Bliddal H; Bech K; Siersbaek-Nielsen K; Friis T
J Endocrinol Invest; 1983 Aug; 6(4):259-62. PubMed ID: 6139399
[TBL] [Abstract][Full Text] [Related]
6. Thyroglobulin, thyrotropin and thyrotropin binding inhibiting immunoglobulins assayed at the withdrawal of antithyroid drug therapy as predictors of relapse of Graves' disease within one year.
Talbot JN; Duron F; Féron R; Aubert P; Milhaud G
J Endocrinol Invest; 1989 Oct; 12(9):589-95. PubMed ID: 2573625
[TBL] [Abstract][Full Text] [Related]
7. Prediction of remission after antithyroid drug treatment in Graves' disease.
Young ET; Steel NR; Taylor JJ; Stephenson AM; Stratton A; Holcombe M; Kendall-Taylor P
Q J Med; 1988 Feb; 66(250):175-89. PubMed ID: 2902655
[TBL] [Abstract][Full Text] [Related]
8. Evidence of a correlation between thyrotrophin receptor binding inhibition and thyroid adenylate cyclase activation by immunoglobulins in Graves' disease before and during long-term antithyroid treatment.
Bliddal H; Bech K; Hyltoft Petersen P; Siersbaek-Nielsen K; Friis T
Acta Endocrinol (Copenh); 1982 Sep; 101(1):35-40. PubMed ID: 6181640
[TBL] [Abstract][Full Text] [Related]
9. [Clinical studies on abnormal thyroid stimulators in patients with Graves' disease. II. Clinical significance of measuring TSAb and TBII in patients with euthyroid Graves' disease and patients with hyperthyroid Graves' disease during antithyroid drug treatment].
Uno C; Nishikawa M
Nihon Naibunpi Gakkai Zasshi; 1988 Mar; 64(3):206-15. PubMed ID: 2456230
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of thyrotropin receptor antibody measurement in the early stages of treatment of Graves' disease with antithyroid drugs.
Michelangeli V; Poon C; Taft J; Newnham H; Topliss D; Colman P
Thyroid; 1998 Feb; 8(2):119-24. PubMed ID: 9510119
[TBL] [Abstract][Full Text] [Related]
11. Clinical validity of a new commercial method for detection of TSH-receptor binding antibodies in sera from patients with Graves' disease treated with antithyroid drugs.
Massart C; Orgiazzi J; Maugendre D
Clin Chim Acta; 2001 Feb; 304(1-2):39-47. PubMed ID: 11165197
[TBL] [Abstract][Full Text] [Related]
12. Antithyroid drugs inhibit radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves' disease.
Nakazato N; Yoshida K; Mori K; Kiso Y; Sayama N; Tani JI; Nakagawa Y; Ito S
Thyroid; 1999 Aug; 9(8):775-9. PubMed ID: 10482369
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of thyrotropin binding inhibiting immunoglobulins (TBII) assay in hyperthyroidism.
Duron F; Talbot JN; Féron R; Aubert P; Milhaud G
Biomed Pharmacother; 1987; 41(7):383-8. PubMed ID: 2895672
[TBL] [Abstract][Full Text] [Related]
14. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
[TBL] [Abstract][Full Text] [Related]
15. Effects of radioiodine on thyrotrophin binding inhibiting immunoglobulins in Graves' disease.
McGregor AM; Petersen MM; Capiferri R; Evered DC; Smith BR; Hall R
Clin Endocrinol (Oxf); 1979 Oct; 11(4):437-44. PubMed ID: 583262
[TBL] [Abstract][Full Text] [Related]
16. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
Takasu N; Oshiro C; Akamine H; Komiya I; Nagata A; Sato Y; Yoshimura H; Ito K
J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248
[TBL] [Abstract][Full Text] [Related]
17. Thyrotropin binding inhibiting immunoglobulins (TBII) in Graves' disease, toxic nodular goitre and autoimmune thyroiditis.
Wägar G; Mäkinen T; Lamberg BA; Gordin A; Apter L; Pekonen F
Ann Clin Res; 1982 Apr; 14(2):83-9. PubMed ID: 6184007
[TBL] [Abstract][Full Text] [Related]
18. Thyroid stimulating immunoglobulins in patients in long-term remission after Graves' disease.
Bliddal H; Bech K; Kirkegaard C
Horm Metab Res; 1984 Nov; 16(11):602-5. PubMed ID: 6210237
[TBL] [Abstract][Full Text] [Related]
19. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
Takasu N; Yamashiro K; Komiya I; Ochi Y; Sato Y; Nagata A
Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
[TBL] [Abstract][Full Text] [Related]
20. Graves' disease in pregnancy: TSH receptor binding inhibiting immunoglobulins and maternal and neonatal thyroid function.
Mortimer RH; Tyack SA; Galligan JP; Perry-Keene DA; Tan YM
Clin Endocrinol (Oxf); 1990 Feb; 32(2):141-52. PubMed ID: 1971773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
